Psyence Biomedical Ltd (NASDAQ: PBM) Drops -22.77% Over A Month, But Analysts Still See Upside Potential

Psyence Biomedical Ltd (NASDAQ:PBM) currently has a daily average trading volume of 5.02M but it saw 9385318 shares traded in last market. With a market cap of 3.76M USD, the company’s current market price of $0.07 came falling about -26.38 while comparing to the previous closing price of $0.09. In past 52 weeks, the stock remained buoying in the range of price level as high as $14.55 and as low as $0.08. In the recent trading on the day, stock has struck highest price mark of $0.068 while lowest mark touched by it was $0.0832.

Taking a look at 20-day trading activity of Psyence Biomedical Ltd (PBM) gives us an average price of $0.1002, while its current price level is -99.52% below from 52-week high level whereas it is -18.20% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.1732. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.76% during that period while stretching the period over a month that increases to 15.35%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 27.26 which implies that the stock is in oversold territory.

Over the week, PBM’s stock price is moving -26.38% down while it is -22.77% when we observe its performance for the past one month. Year-to-date it is -99.25% down and over the past year, the stock is showing a downside performance of -99.36%.

Currently, Psyence Biomedical Ltd’s total number of outstanding shares is 13.39M. Company’s return on equity (ROE) at 1.27%. Stock’s beta reads -0.48. Its return on asset (ROA) is 1.13% on average.